Work

Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosis

Year: 1994

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.44.3_part_1.406

Authors: L. Durelli, M. R. Bongioanni, R. Cavallo, B. Ferrero, R. Ferri, M. F. Ferrio, G. B. Bradac, A. Riva, S. Vai, M. Geuna, L. Bergamini, B. Bergamasco

Institution: University of Turin

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2012270273

FWCI: 15.07

Cites:

Cited by: 123

Related to: 10